Veletri is a treatment for primary pulmonary hypertension.This article has antiplatelet and diastolic effect, can prevent thrombosis.
This report contains market size and forecasts of Veletri in global, including the following market information:
Global Veletri Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Veletri Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Veletri companies in 2021 (%)
The global Veletri market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veletri include Pfizer (US), Sanofi S.A (France), Bayer HealthCare Pharmaceuticals (Germany), Actelion Pharmaceuticals (Switzerland), Daiichi Sankyo (Japan), Eli Lilly and Company (US), Gilead Sciences (US), GlaxoSmithKline Plc (UK) and Nippon Shinyaku (Japan), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veletri manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veletri Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Veletri Market Segment Percentages, by Type, 2021 (%)
Oral Medication
Injection
Global Veletri Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Veletri Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Veletri Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Veletri Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veletri revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Veletri revenues share in global market, 2021 (%)
Key companies Veletri sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Veletri sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer (US)
Sanofi S.A (France)
Bayer HealthCare Pharmaceuticals (Germany)
Actelion Pharmaceuticals (Switzerland)
Daiichi Sankyo (Japan)
Eli Lilly and Company (US)
Gilead Sciences (US)
GlaxoSmithKline Plc (UK)
Nippon Shinyaku (Japan)
Cipla Limited (India)
Arena Pharmaceuticals (US)
The Novartis Group (Switzerland)
United Therapeutics Corp (US)
YM BioSciences (Canada)
Novartis (Canada)
Teva Parenteral (US)
Reata Pharmaceuticals (US)
Merck (US)